Literature DB >> 20544729

Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system.

Nicolas Prevot1, Claire Briet, Hans Lassmann, Isabelle Tardivel, Edwige Roy, Joëlle Morin, Tak W Mak, Anna Tafuri, Christian Boitard.   

Abstract

NOD mice spontaneously develop insulin-dependent diabetes around 10-40 wk of age. Numerous immune gene variants contribute to the autoimmune process. However, genes that direct the autoimmune response toward β cells remain ill defined. In this study, we provide evidence that the Icos and Icosl genes contribute to the diabetes process. Protection from diabetes in ICOS(-/-) and ICOSL(-/-) NOD mice was unexpectedly associated with the development of an autoimmune disorder of the neuro-muscular system, characterized by myositis, sensory ganglionitis and, to a reduced extent, inflammatory infiltrates in the CNS. This syndrome was reproduced upon adoptive transfer of CD4(+) and CD8(+) T cells from diseased donors to naïve NOD.scid recipients. Our data further show that protection from diabetes results from defective activation of autoimmune diabetogenic effector T cells in ICOS(-/-) NOD mice, whereas acceleration of diabetes in BDC2.5 ICOS(-/-) NOD mice is induced by a dominant defect in Treg. Taken together, our findings indicate that costimulation signals play a key role in regulating immune tolerance in peripheral tissues and that the ICOS/ICOSL costimulatory pathway influences the balance between Treg and diabetogenic effector T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544729     DOI: 10.1002/eji.201040416

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.

Authors:  Matthew H Forsberg; Ashley E Ciecko; Kyle J Bednar; Arata Itoh; Kritika Kachapati; William M Ridgway; Yi-Guang Chen
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

2.  Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model.

Authors:  Eroboghene E Ubogu; Nejla Yosef; Robin H Xia; Kazim A Sheikh
Journal:  J Peripher Nerv Syst       Date:  2012-03       Impact factor: 3.494

Review 3.  Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Authors:  Wenhao Chen; Aini Xie; Lawrence Chan
Journal:  Transl Res       Date:  2013-01-22       Impact factor: 7.012

4.  Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice.

Authors:  Nanette Mittereder; Ellen Kuta; Geetha Bhat; Karma Dacosta; Lily I Cheng; Ronald Herbst; Gianluca Carlesso
Journal:  J Immunol       Date:  2016-06-13       Impact factor: 5.422

Review 5.  B7 family checkpoint regulators in immune regulation and disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Randolph J Noelle
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

Review 6.  T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.

Authors:  Roberto Mallone; Vedran Brezar; Christian Boitard
Journal:  Clin Dev Immunol       Date:  2011-07-19

7.  ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.

Authors:  Jian Zheng; Ping-Lung Chan; Yinping Liu; Gang Qin; Zheng Xiang; Kwok-Tai Lam; David B Lewis; Yu-Lung Lau; Wenwei Tu
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 8.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

9.  ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection.

Authors:  Stephen A Redpath; Nienke van der Werf; Ana M Cervera; Andrew S MacDonald; David Gray; Rick M Maizels; Matthew D Taylor
Journal:  Eur J Immunol       Date:  2013-01-31       Impact factor: 5.532

Review 10.  Targeting dendritic cell function during systemic autoimmunity to restore tolerance.

Authors:  Juan P Mackern-Oberti; Fabián Vega; Carolina Llanos; Susan M Bueno; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2014-09-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.